腱炎治療の世界市場レポート 2024年

腱炎治療の市場規模は近年着実に成長しています。2023年の2,116億7,000万米ドルから2024年には2,197億3,000万米ドルへと、CAGR3.8％で拡大します。この期間の成長は、医薬品の進歩、スポーツ傷害の増加、高齢化、職業的要因、意識と教育の向上に起因しています。

腱炎治療の市場規模は、今後数年間で安定した成長が見込まれます。2028年の年間平均成長率（CAGR）は4.3％で、2,595億4,000万米ドルに成長します。予測期間中に予想される成長は、政府の支援や資金提供、個別化医療の採用、再生療法の拡大、非侵襲的治療に対する需要の増加、遠隔モニタリングや遠隔医療の普及といった要因に関連しています。予測期間中に予想される注目すべき動向としては、研究開発の重視、再生療法の進歩、理学療法の進歩、低侵襲治療への注力、遠隔診察のための遠隔医療の活用などが挙げられます。

腱炎治療市場の予測される成長は、スポーツ傷害の有病率の増加によって推進されると予想されます。スポーツ傷害は、筋肉、腱、靭帯、骨、関節に関わるもので、スポーツや身体活動中に発生します。スポーツ傷害に対する腱炎治療では通常、安静、疼痛管理、理学療法を組み合わせて腱の回復を促進し、腫れを抑え、患部をサポートします。例えば、2022年6月、全米安全評議会は、320万人がスポーツやレクリエーション用具に関連した怪我で救急外来で治療を受けたと報告しました。このような傷害の数は、2020年の377,939人に比べ、2021年には20％増加し、409,224人に達しました。したがって、スポーツ傷害の有病率の増加は、腱炎治療市場の推進力となっています。

世界の老人人口の増加は、腱炎治療市場の成長に寄与すると予想されます。一般的に65歳以上の老年人口は、腱鞘炎の発生率が増加しており、高齢者特有のニーズに対応した高度で効果的な治療アプローチが必要とされています。2022年10月に世界保健機関（WHO）が報告したように、世界の60歳人口は2020年の10億人に対し、2030年には14億人に達すると予測されています。さらに、2030年には世界の6人に1人が60歳以上になると推定されています。したがって、世界の老年人口の増加が腱炎治療市場の成長を牽引する構えです。

2023年の腱炎治療市場では北米が最大地域でした。アジア太平洋は、腱炎治療の世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。腱炎治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の腱炎治療市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 治療的処置
• 温冷療法
• 理学療法
• 衝撃波療法
• 外科的治療
• 世界の腱炎治療市場、症状タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• テニス肘
• ゴルファー肘
• 野球肘
• ジャンパー膝
• 水泳肩
• アキレス腱炎
• 世界の腱炎治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 専門クリニック
• 在宅ヘルスケア
• その他

第7章 地域および国の分析

• 世界の腱炎治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の腱炎治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腱炎治療市場の競合情勢
• 腱炎治療市場の企業プロファイル
  • Merck &Co. Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Abbott Laboratories
  • Pfizer Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Tendonitis Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendonitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tendonitis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tendonitis treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment Type: Therapeutic Treatment; Hot And Cold Therapy; Physical Therapy; Shockwave Therapy; Surgical Treatment
• 2) By Condition Type: Tennis Elbow; Golfer's Elbow; Pitcher's Elbow; Jumper's Knee; Swimmer's Shoulder; Achilles Tendonitis
• 3) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users
• Companies Mentioned: Merck & Co. Inc.; Bayer AG; Boehringer Ingelheim GmbH; Abbott Laboratories; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Tendonitis treatment involves methods aimed at reducing inflammation in the tissue that connects muscles and bones, known as tendons. The goal is to apply various therapies that restore strength and flexibility to the affected tendons, alleviating inflammation and pain in the affected area.

The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.

The tendonitis treatment market research report is one of a series of new reports from The Business Research Company that provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tendonitis treatment market size has grown steadily in recent years. It will grow from $211.67 billion in 2023 to $219.73 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The historical period's growth can be ascribed to advancements in pharmaceuticals, a rise in sports injuries, an aging population, occupational factors, and increased awareness and education.

The tendonitis treatment market size is expected to see steady growth in the next few years. It will grow to $259.54 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The anticipated growth in the forecast period is linked to factors such as government support and funding, the adoption of personalized medicine, the expansion of regenerative therapies, an increased demand for non-invasive treatments, and the prevalence of remote monitoring and telehealth. Notable trends expected in the forecast period include an emphasis on research and development, advancements in regenerative therapies, progress in physical therapy, a focus on minimally invasive treatments, and the utilization of telemedicine for remote consultations.

The anticipated growth in the tendonitis treatment market is expected to be propelled by the increasing prevalence of sports injuries. Sports injuries, involving muscles, tendons, ligaments, bones, and joints, occur during sports or physical activities. Tendonitis treatment for sports injuries typically involves a combination of rest, pain management, and physical therapy to facilitate tendon recovery, reduce swelling, and provide support to the affected area. For example, in June 2022, the National Safety Council reported that 3.2 million people sought treatment in emergency departments for injuries related to sports and recreational equipment. The number of such injuries increased by 20% in 2021, reaching 409,224 compared to 377,939 in 2020. Hence, the growing prevalence of sports injuries is a driving force for the tendonitis treatment market.

The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.

Technological innovations represent a prominent trend gaining traction in the tendonitis treatment market. Companies within the market are embracing new technologies to maintain their competitive positions. For example, in September 2021, Stryker Corporation introduced the Citrelock Tendon Fixation Device System, designed to prevent bulk degradation and chronic inflammation during tendon implantation. Citrelock utilizes a tendon thread with a resorbable technology called Citregen, composed of citrate, calcium, and phosphate molecules essential for bone anatomy. This technology provides controlled and homogeneous resorption processes, preventing bulk degradation and chronic inflammation. Additionally, it offers strength comparable to cortical bone and modulus comparable to cancellous bone, ensuring fixation without causing tendon damage.

Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.

In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.

Major companies operating in the tendonitis treatment market report are Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Colfax Corporation, Zimmer Biomet Holdings Inc., Ossur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.

North America was the largest region in the tendonitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Tendonitis Treatment Market Characteristics

3. Tendonitis Treatment Market Trends And Strategies

4. Tendonitis Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Tendonitis Treatment Market Size and Growth

• 5.1. Global Tendonitis Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Tendonitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Tendonitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tendonitis Treatment Market Segmentation

• 6.1. Global Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutic Treatment
• Hot And Cold Therapy
• Physical Therapy
• Shockwave Therapy
• Surgical Treatment
• 6.2. Global Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tennis Elbow
• Golfer's Elbow
• Pitcher's Elbow
• Jumper's Knee
• Swimmer's Shoulder
• Achilles Tendonitis
• 6.3. Global Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Home Healthcare
• Other End-Users

7. Tendonitis Treatment Market Regional And Country Analysis

• 7.1. Global Tendonitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Tendonitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tendonitis Treatment Market

• 8.1. Asia-Pacific Tendonitis Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tendonitis Treatment Market

• 9.1. China Tendonitis Treatment Market Overview
• 9.2. China Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tendonitis Treatment Market

• 10.1. India Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tendonitis Treatment Market

• 11.1. Japan Tendonitis Treatment Market Overview
• 11.2. Japan Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tendonitis Treatment Market

• 12.1. Australia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tendonitis Treatment Market

• 13.1. Indonesia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tendonitis Treatment Market

• 14.1. South Korea Tendonitis Treatment Market Overview
• 14.2. South Korea Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tendonitis Treatment Market

• 15.1. Western Europe Tendonitis Treatment Market Overview
• 15.2. Western Europe Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tendonitis Treatment Market

• 16.1. UK Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tendonitis Treatment Market

• 17.1. Germany Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tendonitis Treatment Market

• 18.1. France Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tendonitis Treatment Market

• 19.1. Italy Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tendonitis Treatment Market

• 20.1. Spain Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tendonitis Treatment Market

• 21.1. Eastern Europe Tendonitis Treatment Market Overview
• 21.2. Eastern Europe Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tendonitis Treatment Market

• 22.1. Russia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tendonitis Treatment Market

• 23.1. North America Tendonitis Treatment Market Overview
• 23.2. North America Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tendonitis Treatment Market

• 24.1. USA Tendonitis Treatment Market Overview
• 24.2. USA Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tendonitis Treatment Market

• 25.1. Canada Tendonitis Treatment Market Overview
• 25.2. Canada Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tendonitis Treatment Market

• 26.1. South America Tendonitis Treatment Market Overview
• 26.2. South America Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tendonitis Treatment Market

• 27.1. Brazil Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tendonitis Treatment Market

• 28.1. Middle East Tendonitis Treatment Market Overview
• 28.2. Middle East Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tendonitis Treatment Market

• 29.1. Africa Tendonitis Treatment Market Overview
• 29.2. Africa Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tendonitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tendonitis Treatment Market Competitive Landscape
• 30.2. Tendonitis Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Boehringer Ingelheim GmbH
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Abbott Laboratories
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Pfizer Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Tendonitis Treatment Market Competitive Benchmarking

32. Global Tendonitis Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Tendonitis Treatment Market

34. Tendonitis Treatment Market Future Outlook and Potential Analysis

• 34.1 Tendonitis Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Tendonitis Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Tendonitis Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer